Core Laboratories (CLB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CLB Core Laboratories

Watchlist

19.130
-0.150-0.78%

Trading Oct 31 14:06 ET

898.16MMarket Cap35.43P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Citi Maintains Core Laboratories(CLB.US) With Sell Rating, Maintains Target Price $14
Moomoo NewsOct 31 08:34 ET · Ratings
Evercore Maintains Core Laboratories(CLB.US) With Hold Rating, Cuts Target Price to $24
Moomoo NewsOct 25 09:40 ET · Ratings
Express News | Core Laboratories Inc : Zephirin Group Raises to Buy From Hold; Raises Price Objective to $22 From $18
ReutersOct 25 02:49 ET
Core Laboratories | 10-Q: Q3 2024 Earnings Report
SECOct 24 17:34 ET · Announcements
Core Laboratories Inc. (CLB) Q3 2024 Earnings Call Transcript Summary
moomoo AIOct 24 12:59 ET · Conference Call
Core Laboratories Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Adjusted EPS Results.
BenzingaOct 24 10:12 ET

Comments

NASSER09

Apr 23 11:53

$Core Laboratories (CLB.US)$ buy

Moomoo AI

Mar 2 07:13

Core Laboratories' declining ROCE trend signals a mature business possibly facing new competition or smaller margins. Unless metrics shift positively, consider other investment opportunities.

Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture

Moomoo AI

Feb 3 07:26

Analysts are more negative on Core Laboratories after recent results, leading to a minor EPS downgrade for next year. Despite this, the unchanged consensus price target suggests lower forecast earnings won't affect the stock price. However, the company's revenue growth is expected to lag the industry average.

Core Laboratories Inc. Just Missed EPS By 6.0%: Here's What Analysts Think Will Happen Next

Moomoo AI

Jan 27 06:42

Despite Core Laboratories' move to profitability, the ongoing drop in revenue and share price indicates negative market sentiment. Investors are urged to consider other factors before investing.

Core Laboratories' (NYSE:CLB) Earnings Have Declined Over Five Years, Contributing to Shareholders 74% Loss

Moomoo AI

Jan 2 06:34

Investors project strong growth for Core Laboratories given the high P/E ratio, showing confidence in the company's future earnings. Other investment risks should also be considered while investing, not just the P/E ratio.

Shareholders Should Be Pleased With Core Laboratories Inc.'s (NYSE:CLB) Price

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

CLB Core Laboratories

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target